precision medicine

Industry leaders predict the most exciting advances in drug discovery and development in the coming year.

A new metabolic model predicted short-chain fatty acid production based on an individual’s microbiome, diet, and prebiotic or probiotic input.

Researchers harness pharmacogenomics to understand why individual patients react differently to opioids for pain relief. 

By watching brain organoids develop, researchers observed surprising abnormalities caused by mutations in a gene related to early-onset Alzheimer’s disease.

Researchers use cell-free DNA circulating in the blood of patients with rheumatoid arthritis to match them with the most effective drugs. 

Researchers use mRNA to create cancer vaccines that are personalized to each individual’s unique tumor.

AI simulates how cancer cells respond to therapy, guiding optimal treatment strategies.

Multiomics data analysis identified structural mutations in tumor genomes with important implications for cancer treatment.

A new form of brain stimulation treatment that responds to a patient’s brain activity could be life changing for people with neurological and psychiatric disorders.

Amit Etkin embraces the diverse underpinnings of depression and other psychiatric disorders and pairs patients with drugs based on their unique biology.